Skip to content

Microbot Medical MBOT Foreign operations

Foreign operations at other companies

TFX
TeleflexTFX
-66.6%-70.0pp

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's foreign operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's foreign operations?
Microbot Medical (MBOT) reported foreign operations of 1% in Q4 2025.
What does foreign operations mean?
Reflects the effective tax rate adjustment attributable to the company's foreign operations compared to the domestic statutory rate. It is used to assess how international tax structures influence the overall corporate tax burden.